Geoffrey Wade Smith

Insider Reports History

Entity
Individual
Location
6740 Shady Oak Road, Eden Prairie, MN
Signature
/s/ Todd Finger, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Geoffrey Wade Smith:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Orchestra BioMed Holdings, Inc. Director Common Stock 1.05M $16.8M $16.04 Jan 26, 2023 By Ascent Biomedical Ventures II, LP
Orchestra BioMed Holdings, Inc. Director Common Stock 257K $4.12M $16.04 Jan 26, 2023 By Ascent Biomedical Ventures Synecor, LP
Orchestra BioMed Holdings, Inc. Director Common Stock 201K $3.23M $16.04 Jan 26, 2023 By Ascent Biomedical Ventures II NY, LP
Orchestra BioMed Holdings, Inc. Director Common Stock, par value $0.0001 per share ("Common Stock") 20.9K $99.3K $4.75 Jul 20, 2023 Direct
Orchestra BioMed Holdings, Inc. Director Common Stock 3.49K $55.9K $16.04 Jan 26, 2023 Direct
Orchestra BioMed Holdings, Inc. Director Right to Receive Earnout Shares 228K Apr 12, 2023 By Ascent Biomedical Ventures II, LP
Orchestra BioMed Holdings, Inc. Director Warrants (Right to Buy) 136K Jan 26, 2023 By Ascent Biomedical Ventures II, LP
Orchestra BioMed Holdings, Inc. Director Right to Receive Earnout Shares 55.8K Apr 12, 2023 By Ascent Biomedical Ventures Synecor, LP
Orchestra BioMed Holdings, Inc. Director Warrants (Right to Buy) 43.9K Jan 26, 2023 By Ascent Biomedical Ventures II NY, LP
Orchestra BioMed Holdings, Inc. Director Right to Receive Earnout Shares 43.8K Apr 12, 2023 By Ascent Biomedical Ventures II NY, LP
Orchestra BioMed Holdings, Inc. Director Stock Options (Right to Buy) 23.3K Jan 26, 2023 Direct
Orchestra BioMed Holdings, Inc. Director Warrants (Right to Buy) 15K Jan 26, 2023 Direct
Orchestra BioMed Holdings, Inc. Director Right to Receive Earnout Shares 758 Apr 12, 2023 Direct
Orchestra BioMed Holdings, Inc. Director Warrants (Right to Buy) 519 Jan 26, 2023 By Ascent Biomedical Ventures Synecor, LP

Insider Reports Filed by Geoffrey Wade Smith

Symbol Company Period Transactions Value $ Form Type Date Filed Role
OBIO Orchestra BioMed Holdings, Inc. Jul 20, 2023 1 $0 4 Jul 24, 2023 Director
OBIO Orchestra BioMed Holdings, Inc. Apr 12, 2023 8 $0 4 May 8, 2023 Director
OBIO Orchestra BioMed Holdings, Inc. Jan 26, 2023 4 $0 4/A May 8, 2023 Director
OBIO Orchestra BioMed Holdings, Inc. Jan 26, 2023 0 $0 3 Jan 30, 2023 Director